Impact of change in the price of percutaneous coronary intervention devices on medical expenses

Circulation Journal

Volumn 67, Issue 7, 2003, Pages 576-578

  Kuroda, Nakabumi ^a   Kobayashi, Yoshio ^a,b   Desai, Kartik ^c   Costantini, Costantino ^c   Kobayashi, Mika ^c   Komuro, Issei ^b  

^a Chiba Prefecture Hospital of Sawara   (Japan)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^c NONE

Author keywords

Angioplasty; Cost analysis; Stent

Indexed keywords

ARTICLE; BALLOON CATHETER; CORONARY STENT; DEVICE; GUIDE WIRE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART CATHETERIZATION; HUMAN; INTERVENTIONAL RADIOLOGY; INTRAVASCULAR ULTRASOUND; MEDICAL FEE;

EID: 0037593658     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.67.576     Document Type: Article

References (20)

1. Kobayashi Y, De Gregorio J, Yamamoto Y, Komiyama N, Miyazaki A, Masuda Y. Cost analysis between stent and conventional balloon angioplasty. Jpn Circ J 2000; 64: 161-164.
2. Cohen DJ, Taira DA, Berezin R, Cox DA, Morice MC, Stone GW, et al. Cost-effectiveness of coronary stenting in acute myocardial infarction: Results from the stent primary angioplasty in myocardial infarction (stent-PAMI) trial. Circulation 2001; 104: 3039-3045.
3. No authors listed. Stent prices expected to decline. Hosp Mater Manage 2001; 26: 1, 12-13.
4. Choi JW, Goodreau LM, Davidson CJ. Resource utilization and clinical outcomes of coronary stenting: A comparison of intravascular ultrasound and angiographical guided stent implantation. Am Heart J 2001; 142: 112-118.
5. Cohen DJ, Krumholz HM, Sukin CA, Ho KKL, Siegrist RB, Cleman M, et al. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty: Result from a randomized clinical trial. Circulation 1995; 92: 2480-2487.
6. Cohen DJ, Breall JA, Ho KKL, Weintraub RM, Kuntz RE, Weinstein MC, et al. Economics of elective coronary revascularization: Comparison of costs and charges for conventional angioplasty, directional atherectomy, stenting and bypass surgery. J Am Coll Cardiol 1993; 22: 1052-1059.
7. Cohen DJ, Breall JA, Ho KKL, Kuntz RE, Goldman L, Baim DS, et al. Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease: Use of a decision-analytic model. Circulation 1994; 89: 1859-1874.
8. Shihara M, Tsutsui H, Tsuchihashi M, Shigematsu H, Yamamoto S, Koike G, et al. Coronary revascularization in Japan. Jpn Circ J 2001; 65: 1005-1010.
9. Sculpher MJ, Smith DH, Clayton T, Henderson RA, Buxton MJ, Pocock SJ, et al. Coronary angioplasty versus medical therapy for angina: Health service costs based on the second Randomized Intervention Treatment of Angina (RITA-2) trial. Eur Heart J 2002; 23: 1291-1300.
10. Serruys PW, de Bruyne B, Carlier S, Sousa JE, Piek J, Muramatsu T, et al. Randomized comparison of primary stenting and provisional balloon angioplasty guided by flow velocity measurement: Doppler Endpoints Balloon Angioplasty Trial Europe (DEBATE) II Study Group. Circulation 2000; 102: 2930-2937.
11. Weinstein MC, Stason WB. Cost-effectiveness of coronary artery bypass surgery. Circulation 1982; 66(Suppl III): III-56-1II-66.
12. Goldman L, Sia STB, Cook EF, Rutherford JD, Weinstein MC. Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction. N Engl J Med 1988; 319: 152-157.
13. Krumholz HM, Pasternak RC, Weinstein MC, Friesinger GC, Ridker PM, Tosteson ANA, et al. Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction. N Engl J Med 1992; 327: 7-13.
14. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions: A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
15. Sharma S, Bhambi B, Nyitray W. Sirolimus-eluting coronary stents. N Engl J Med 2002; 347: 1285.
16. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schonberger JP, et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001; 344: 1117-1124.
17. Rodriguez A, Bemardi V, Navia J, Baldi J, Grinfeld L, Martinez J, et al. Argentine Randomized Study: Coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up results: ERACI II Investigators. J Am Coll Cardiol 2001; 37: 51-58.
18. SoS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): A randomised controlled trial. Lancet 2002; 360: 965-970.
19. Reynolds MR, Neil N, Ho KK, Berezin R, Cosgrove RS, Lager RA, et al. Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: A single-center US experience. Am Heart J 2003; 145: 334-342.
20. Bucher HC, Hengstler P, Schindler C, Guyatt GH. Percutaneous transluminal coronary angioplasty versus medical treatment for nonacute coronary heart disease: Meta-analysis of randomised controlled trials. BMJ 2000; 321: 73-77.